Challenges in diagnosing drug-resistant tuberculosis (DR-TB) contribute to a diagnostic gap. Design-locked Targeted Sequencing (TS) assays have the potential to improve DR-TB diagnosis and management.
Supplementary Figure S1 to S7 for manuscript (Exploration of a novel prognostic nomogram and diagnostic biomarkers based on the activity variations of hallmark gene sets in hepatocellular carcinoma).